Sanofi-aventis has signed a global strategic alliance with Avila Therapeutics that is worth more than US$800 M, including US$40 M upfront and as much as US$770 M in milestone payments...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: PharmaDeals Ltd